openPR Logo
Press release

Anti-Infective Drugs Market (Antibiotics, Antivirals, Antifungals And Others) Research Report

08-22-2019 07:05 AM CET | Health & Medicine

Press release from: The Business Research Company

The anti-infective drugs market (https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market) is expected to benefit from the latest developments in drug discovery procedures such as stem cells and organ-on-chip (OOC) technologies. OOCs are micro-engineered biometric systems that simulate the activities, mechanics and physiological responses of organ systems. Drug trial processes such as target identification, validation, and screening are being executed through OOC and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Another area of development is physiology-simulation modelling, in which the integrated physiology of the human organism, in both health and disease, is simulated through a computer program.

Companies in the anti-infective drugs market are strategically partnering and collaborating with other companies to broaden their product portfolios. In December 2014, Chimerix, Inc. and ContraVir Pharmaceuticals, Inc. entered into a strategic collaboration for the clinical development and commercialization of antiviral drug CMX157. In December 2016, Evotec AG, a biotechnology company, entered into a strategic alliance with Forge Therapeutics, Inc., to advance its novel Gram-negative antibiotic program targeting LpxC for the treatment of bacterial infections. In October 2018, AiCuris, a leading pharmaceutical company in the discovery and development of innovative drugs targeting infectious diseases, and Cyclenium Pharma Inc., an emerging pharmaceutical company specializing in the discovery of novel therapeutics, entered into a collaboration to develop novel anti-infective drugs.

Request a Sample of this report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2348&type=smp .

Sub-Segmentation The antibiotics market can be sub-segmented by product type into
a) ß-Lactams
b) Quinolones
c) Macrolides
d) Aminoglycosides
e) Others

The antivirals market can be sub-segmented by therapeutic type into
a) HIV AIDS Therapeutics
b) Hepatitis Therapeutics
c) Herpes Therapeutics
d) Influenza Therapeutics

The antifungals market can be sub-segmented by product type into
a) Azoles
b) Others

Inquire for DISCOUNT offered on this research @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2348&type=discount .

The Business Research Company
47 Anchorage Point,
42 Cuba Street, Canary Wharf,
London, England,
E14 8NE.
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Linkedin: https://in.linkedin.com/company/the-business-research-company

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Infective Drugs Market (Antibiotics, Antivirals, Antifungals And Others) Research Report here

News-ID: 1824713 • Views: 263

More Releases from The Business Research Company

Global Management Consulting Market 2019 Trends: Analysis By Segments, By Countr …
The global management consulting market expected to reach a value of nearly $977.3 billion in 2018, having grown at a compound annual growth rate (CAGR) of 8.6% since 2014, and is expected to grow at a CAGR of 10.6% to nearly $1,460.2 billion by 2022. Browse Complete report @ https://www.thebusinessresearchcompany.com/report/management-consulting-market Major Competitors are Deloitte Touche Tohmatsu Limited, Accenture Plc, International Business Machines Corporation, Ernst & Young Global Limited, PricewaterhouseCoopers (PwC) Growth in the
Methanol Market By Products (Plastics & Polymers, Chlor-Alkali And Inorganics, O …
The Methanol market is expected to grow at a CAGR of around 12% to nearly $19 billion by 2022. Growth in the methanol market in the historic period resulted from low natural gas prices, developing economies, increased demand for vehicles, and low interest environment. Factor that negatively affected growth in the historic period was safety concerns. Going forward, economic growth and increasing end use applications of methanol will drive growth. Browse
Plastic Pipes and Shapes Manufacturing Market By End Users Analysis - Oil and Ga …
The global plastic pipes and shapes market reached a value of nearly $106.5 billion in 2018, having grown at a compound annual growth rate (CAGR) of 5.3% since 2014, and is expected to grow at a CAGR of 6.5% to nearly $137.1 billion by 2022. Browse Complete report @ https://www.thebusinessresearchcompany.com/report/plastic-pipes-and-shapes-market Major Competitors are Mexichem, S.A.B. de C.V., Aliaxis Group S.A. / N.V., China Lesso Group Holdings Limited, Chevron Phillips Chemical Company LLC,
Global Surveying And Mapping Market Size, Growth, Trends & 2022 Forecast Report
The surveying and mapping market consists of sales of surveying and mapping services by entities that provide surveying and mapping services. Surveying and mapping involve measurement of the earth’s surface including the sea floor, layout and measurement of project facilities, and preparation of maps. Browse Complete report @ https://www.thebusinessresearchcompany.com/report/surveying-and-mapping-services-market Major Competitors are Secom Group, Fugro N.V., AECOM, Stantec Inc., Mott MacDonald Growth in the historic period resulted from the growth in the global

All 5 Releases


More Releases for Therapeutics

Lipodystrophy Therapeutics- Pipeline Analysis 2018 | Ionis Pharmaceuticals, Inc. …
Lipodystrophy is a rare medical condition which involves problems with fat production, usage, and storage. It is categorized into two types; congenital and acquired lipodystrophy. Download the sample report @ https://www.pharmaproff.com/request-sample/1077 Congenital lipodystrophies include congenital generalized lipodystrophy, familial partial lipodystrophy, and marfanoid progeroid lipodystrophy syndrome; while acquired lipodystrophy includes acquired partial lipodystrophy, acquired generalized lipodystrophy, centrifugal abdominal lipodystrophy, lipoatrophia annularis, localized lipodystrophy and HIV-associated lipodystrophy. Get the detailed analysis @ https://www.pharmaproff.com/report/lipodystrophy-therapeutics-pipeline-analysis The
Dravet Syndrome Therapeutics- Pipeline Analysis 2018 | Zogenix, Inc., Ovid Thera …
Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity. Download the sample report @ https://www.pharmaproff.com/request-sample/1098 It severely affects the person’s quality of life and around 10-20% of the patient are estimated to die due
Pontine Glioma Therapeutics- Pipeline Analysis 2018 | Y-mAbs Therapeutics, Inc.
Pontine glioma is a malignant tumour which develops from the brain stem cells. Based on the grade of growth, it is categorized into anaplastic astrocytomas and glioblastoma multiforme (GBM). Download the sample report @ https://www.pharmaproff.com/request-sample/1117 Pontine glioma is more prevalent in children than adults. The common signs and symptoms of pontine glioma are squints, swallowing problems, slurred speech, facial weakness, abnormal gait, difficulty in writing and changes in personality and behaviour.
Rheumatology Therapeutics Market
Global Rheumatology Therapeutics Market: Snapshot A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. This has led to the emergence of many new drugs. Their swift approvals by the appropriate authorities has also led to the growth in the market. A report by Transparency Market Research uncovers after in-depth study that the global rheumatology
Bone Degeneration Therapeutics Market
Bone degeneration is characterized by deterioration of articular cartilage covering the joints. Cartilage aids free movement of the joint without any resistance. Reduction in flexibility of the joint due to deterioration of cartilage leads to inflammation, compressed nerves, and pain. Aging is one of the natural causes of bone degeneration, which is also fueled by several conditions such as injuries, congenital disorders, diabetes, and obesity. Symptoms of degenerative bone disorders
Global Dyslipidemia Therapeutics Market
Dyslipidemia is one of the metabolic disorder, which is described by unbalanced level and thickness of lipoproteins and triglycerides. The disorder also includes protein deficiency and over production. These disorders can be caused by increase in the serum total cholesterol, triglyceride concentrations, and low-density lipoprotein (LDL) cholesterol, and a decrease in the high-density lipoprotein (HDL) cholesterol concentration. These condition are mainly associated with cardiovascular or coronary heart disease. The other